Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers

Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers

Background: Modified 5-fluorouracil/leucovorin/irinotecan (mFOLFIRI) is a commonly used combination second-line chemotherapeutic regimen in advanced gastric cancer (AGC). Materials and Methods: Patients diagnosed with AGC, receiving biweekly mFOLFIRI between July 2013 and June 2016, as second-line c...

Full description

Bibliographic Details
Main Authors: Anant Ramaswamy, Vikas Ostwal, Kushal Gupta, Vijai Simha, Anup Toshniwal, Nitin Shetty, Chaitali Nashikkar, Sarika Mandavkar, Sudeep Gupta
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-01-01
Series:South Asian Journal of Cancer
Subjects:
Advanced gastric cancers
modified 5-fluorouracil/leucovorin/irinotecan
second-line chemotherapy
Online Access:http://journal.sajc.org/article.asp?issn=2278-330X;year=2018;volume=7;issue=4;spage=219;epage=222;aulast=Ramaswamy

Similar Items

Similar Items